bullish

MariMed

MariMed, Inc. - 3Q23 Revenue Exceeds Estimates; Adjusted EBITDA In Line

347 Views11 Nov 2023 06:44
Issuer-paid
MariMed report 3Q revenue of $38.8 million, which was slightly ahead of our estimate of $38.5 million. This represents a 6.3% increase Q/Q and a 14.4% improvement Y/Y.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Water Tower Research
Research from Water Tower Research
Water Tower Research
Equity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • MariMed, Inc. - 3Q23 Revenue Exceeds Estimates; Adjusted EBITDA In Line
    11 Nov 2023
x